Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Leukemia. 2023 Sep 5;37(11):2261–2275. doi: 10.1038/s41375-023-02014-8

Fig. 4. Restored the hematopoietic progenitor populations and lymphopoiesis of miR-9-1-deficient BM cells after transplantation.

Fig. 4

BM cells from growth-retarded miR-9-1−/− or wild-type control mice (CD45.2+) were transplanted into lethally irradiated CD45.1+ recipients. About eight weeks after transplantation, the recipients were analyzed. A The numbers of total BM cells, splenocytes and thymocytes the recipients that received BM cells from miR-9-1−/− and controls mice. B The percentages and numbers of various CD45.2+ hematopoietic progenitors in the BM of the recipients that received BM cells from miR-9-1−/− and controls mice. Percentages indicate LT-HSC, ST-HSC and MPP in the gated CD45.2+LinIL-7RLSK population. C The percentages and numbers of B cells at the different developmental stages in the BM of the recipients that received BM cells from miR-9-1−/− and controls mice. Percentages indicate pro/pre-, immature (IM) and mature (M) B cells in the gated CD45.2+ population. Data shown are obtained from 4 recipients that received control or miR-9-1−/− BM cells. Each dot represents an individual mouse. Mean ± SD is shown. *, p < 0.05; **, p < 0.01.